Detrimental effects of nitric oxide on mesenteric circulation during endotoxaemia and its reversal by aminoguanidine

Eur J Surg. 2000 Nov;166(11):888-93. doi: 10.1080/110241500447290.

Abstract

Objective: To investigate the effect of endotoxaemia on rat mesenteric vascular bed and plasma nitrite concentrations, the possible beneficial effect of aminoguanidine (the selective inducible nitric oxide synthase inhibitor) compared with N(G)-nitro-L-arginine methyl ester (L-NAME) (non-selective nitric oxide synthase inhibitor).

Design: Randomised experiment.

Setting: University surgical research laboratory, Turkey.

Subjects: 75 Wistar rats.

Interventions: Rats were divided into control (n = 30) and endotoxaemia (n = 42) groups. Endotoxaemia was produced by intraperitoneal injection of lipopolysaccharide 20 mg/kg. Subgroups were given either aminoguanidine or L-NAME.

Main outcome measures: After 4 hours, isolated perfused mesenteric preparations were obtained and pressor responses to phenylephrine and vasodilatation responses to acetylcholine were evaluated, and plasma nitrite concentrations measured.

Results: Pressor response to phenylephrine did not alter but vasodilatation in response to acetylcholine was significantly reduced during endotoxaemia. Pretreatment with aminoguanidine prevented the impairment of the response to acetylcholine. However, L-NAME was ineffective. In the control group, aminoguanidine and L-NAME did not alter the vascular reactivity. The baseline plasma nitrite concentrations in the control group were increased 5-fold during endotoxaemia. This increase was significantly reduced with aminoguanidine but not with L-NAME.

Conclusion: The protection achieved by aminoguanidine but not L-NAME suggested that nitric oxide produced by inducible nitric oxide synthase had a role in the impairment of endothelial response during endotoxaemia, and confirmed the importance of selective inducible nitric oxide synthase inhibition to achieve beneficial effects in endotoxaemia.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Algorithms
  • Analysis of Variance
  • Animals
  • Data Interpretation, Statistical
  • Endotoxemia / physiopathology*
  • Enzyme Inhibitors / pharmacology
  • Female
  • Guanidines / pharmacology*
  • In Vitro Techniques
  • Lipopolysaccharides / administration & dosage
  • Male
  • Mesentery / drug effects
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / physiology*
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Nitrites / blood*
  • Phenylephrine / pharmacology
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Splanchnic Circulation* / drug effects
  • Time Factors
  • Vasoconstriction / physiology
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / physiology
  • Vasodilator Agents / pharmacology

Substances

  • Enzyme Inhibitors
  • Guanidines
  • Lipopolysaccharides
  • Nitrites
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Phenylephrine
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Acetylcholine
  • pimagedine
  • NG-Nitroarginine Methyl Ester